Elobixibat
CAS: 439087-18-0
Ref. 3D-PSA08718
| 1mg | 517.00 € | ||
| 2mg | 801.00 € | ||
| 5mg | 1,160.00 € | ||
| 10mg | 1,739.00 € | ||
| 500µg | 364.00 € |
Product Information
- Glycine, (2R)-N-[[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- AZD 7806
- Glycine, (2R)-N-[2-[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- (2R)-N-[2-[[3,3-Dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycylglycine
Elobixibat is a drug that has been studied for its potential to treat cancer, chronic kidney disease and other diseases. It is a prodrug that is hydrolyzed in vivo to elobixibat acid, its active form. Elobixibat acid inhibits the sodium taurocholate co-transporting polypeptide (NTCP), which transports bile acids and sodium taurocholate into the small intestine. This inhibition leads to decreased bile acid levels and reduced symptoms of chronic kidney disease. Elobixibat acid also blocks the growth factor receptor tyrosine kinase c-Met, which can have therapeutic benefits for cancers such as colorectal cancer.
Chemical properties
Technical inquiry about: 3D-PSA08718 Elobixibat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
